张 磊, 陈 颖, 刘文欣, 王耕辛, 吴明富①, 马 丁①, 郝 权. siRNA 抑制Sema4C 基因表达对人乳腺癌细胞恶性行为的影响*[J]. 中国肿瘤临床, 2010, 37(16): 926-929. DOI: 10.3969/j.issn.1000-8179.2010.16.009
引用本文: 张 磊, 陈 颖, 刘文欣, 王耕辛, 吴明富①, 马 丁①, 郝 权. siRNA 抑制Sema4C 基因表达对人乳腺癌细胞恶性行为的影响*[J]. 中国肿瘤临床, 2010, 37(16): 926-929. DOI: 10.3969/j.issn.1000-8179.2010.16.009
ZHANG Lei1, CHEN Ying1, LIU Wenxin1, WANG Gengxin1, WU Mingfu2, MA Ding2, HAO Quan1. The Effect of Specific Inhibition of Semaphorin4C (Sema4C) Gene Expression by Small Interfering RNA on the Malignant Behavior of Human Breast Cancer Cell Line MDA-MB-231[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(16): 926-929. DOI: 10.3969/j.issn.1000-8179.2010.16.009
Citation: ZHANG Lei1, CHEN Ying1, LIU Wenxin1, WANG Gengxin1, WU Mingfu2, MA Ding2, HAO Quan1. The Effect of Specific Inhibition of Semaphorin4C (Sema4C) Gene Expression by Small Interfering RNA on the Malignant Behavior of Human Breast Cancer Cell Line MDA-MB-231[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(16): 926-929. DOI: 10.3969/j.issn.1000-8179.2010.16.009

siRNA 抑制Sema4C 基因表达对人乳腺癌细胞恶性行为的影响*

The Effect of Specific Inhibition of Semaphorin4C (Sema4C) Gene Expression by Small Interfering RNA on the Malignant Behavior of Human Breast Cancer Cell Line MDA-MB-231

  • 摘要: 目的:研究小干扰RNA(small interf ering RNA,siRNA )抑制轴突导向蛋白分子(Semaphorin 4C,Sema4C)基因的表达对人乳腺癌细胞MDA-MB-231 体外迁移、侵袭及增殖的影响,并初步探讨其作用机制。方法:根据Sema4C 基因设计序列特异性的siRNA(Sema4C-siRNA ),在脂质体介导下转染MDA-MB-231 细胞,Western blot方法检测基因封闭效应,利用细胞划痕实验、Tran ?swell小室侵袭实验及CFSE流式细胞仪方法检测细胞转染前后迁移、侵袭及增殖能力的变化,Western blot检测磷酸化AKT(p-AKT )在转染前后细胞中表达的变化。结果:转染Sema4C-siRNA 72小时后,乳腺癌MDA-MB-231 细胞株(MDA-MB-231/Si)Sema4C 蛋白表达明显下降,与未转染细胞MDA-MB-231 相比,MDA-MB-231/Si细胞体外迁移能力减弱,侵袭及增殖能力明显下降;p-AKT 表达水平在MDA-MB-231/Si细胞中明显降低。结论:Sema4C-SiRNA 转染人乳腺癌MDA-MB-231 细胞可下调细胞中Sema4C 蛋白表达水平,Sema4C-SiRNA 对MDA-MB-231 细胞的体外迁移、侵袭和增殖有抑制作用,这可能与p-AKT 的下调有关。

     

    Abstract: Objective: To study the effect of specific inhibition of Semaphorin 4C (Sema4C) gene expression by small interfering RNA (siRNA) on the migration, invasion and proliferation of highly metastatic human breast cancer cell line MDA-MB-231 , in vitro. Methods:The Sema 4C siRNA was designed by web based software, synthesized and then transfect -ed into MDA-MB- 231 cell line by lipofectamine 2000 reagent. Western blot was used to analyze the effect of the siRNA transfection. The migration, invasion and proliferation of the Sema 4C-siRNA transfected cells were assessed by monolayer wound healing assay, transwell cell invasion assay and CFSE-flow cytometry. The expression of p-AKT protein in untrans-fected cells, negative control-transfected MDA-MB- 231 cells and Sema 4C-siRNA-transfected MDA-MB- 231 cells were stud -ied by Western blot analysis. Results: Significant down-regulation of the Sema 4C protein was found at72hours after trans-fection of the Sema 4C-siRNA. Compared with those of untransfected cells and negative control transfected cells, the migra-tion, invasion and proliferation ability of Sema 4C-siRNA-transfected MDA-MB- 231 cells were notably weakened. The pro-tein level of p-AKT was lower in the Sema 4C-siRNA-transfected MDA-MB- 231 cells. Conclusion:The in vitro transient trans-fection of synthesized Sema 4C-siRNA on the MDA-MB- 231 cell line can down-regulate the expression of Sema4C protein in the cells. Sema 4C-siRNA plays a vital role in suppressing migration, invasion and proliferation of MDA-MB-231 cells, which may be related to PI 3K-AKT cell signal pathway.

     

/

返回文章
返回